Disclosures for "Calcitonin Gene-related Peptide Induces Headache Attacks in People with Idiopathic Intracranial Hypertension"
-
Dr. Yiangou has nothing to disclose.
-
Dr. Do has nothing to disclose.
-
Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Thea pharmaceuticals. Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Abbvie. The institution of Prof. Mollan has received research support from National Institute of Health Research (UK) . The institution of Prof. Mollan has received research support from Heidelberg Engineering. Prof. Mollan has received publishing royalties from a publication relating to health care. Prof. Mollan has a non-compensated relationship as a Board Member (non-voting) with North American Neuro-ophthalmology Society that is relevant to AAN interests or activities.
-
Dr. THALLER has nothing to disclose.
-
Dr. Mitchell has received personal compensation for serving as an employee of Ministry of Defence.
-
Mr. Tsermoulas has nothing to disclose.
-
Dr. Hill has nothing to disclose.
-
Prof. Lucas has nothing to disclose.
-
Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Ashina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GlaxoSmithKline. Dr. Ashina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Incyte. The institution of Dr. Ashina has received research support from The Lundbeck Foundation. The institution of Dr. Ashina has received research support from Novo Nordisk Foundation . The institution of Dr. Ashina has received research support from Danish National Research Foundation . Dr. Ashina has received publishing royalties from a publication relating to health care.
-
Dr. Sinclair has received personal compensation for serving as an employee of Invex Therapeutics. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Sinclair has stock in Invex Therapeutics (unclear what the company is developing but no longer working in the field of Idiopathic Intracranial Hypertension). The institution of Dr. Sinclair has received research support from DOD. The institution of Dr. Sinclair has received research support from MOD.